Skip to main content
Fig. 5 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 5

From: Bronchogenic carcinoma: the added value of FDG PET/CT advanced volumetric and metabolic parameters in initial evaluation and their impact on prognosis and clinical outcome

Fig. 5

A 45-year-old male patient presented with the left lower lung lobe hypermetabolic lesion which was pathologically proven as bronchogenic carcinoma (grade 2). A Whole-body PET-MIP image and B axial fused image showing the left lower lung lobe neoplastic lung mass with SUVmax 7, MTV 14.7 ml and TLG reaching 90 g/ml. C Axial fused image showed enlarged hypermetabolic metastatic left hilar and mediastinal lymph nodes. D Axial fused image showed multiple metastatic bi-lobar hepatic focal lesions as well as osseous vertebral body deposit. The patient received chemotherapy and was referred for follow-up after 3 months. The new scan revealed significant regressive course of the primary pulmonary mass E and hepatic deposits F as well as resolution of the infiltrated lymph nodes G and vertebral osseous deposits H reflecting favorable response to therapy

Back to article page